AI-generated summary
The authors studied WS1 fibroblast cells exposed to 660 nm photobiomodulation at 5 J/cm2 under normal, wounded, diabetic and diabetic wounded conditions in laboratory culture. They report increased cell viability in all irradiated models and an increase in myofibroblast markers in diabetic wounded cells, independent of the TGF-β1/Smad pathway.
- Who or what was studied
- WS1 fibroblast cells in normal, normal wounded, diabetic and diabetic wounded in vitro models
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted on cultured cells rather than people, and the abstract does not report a sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 5 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Wound healing, Wavelength, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.